Cardiol Therapeutics (CRDL) Non-Current Assets (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Non-Current Assets came in at $101337.0 in Q1 2026, down 20.34% YoY from $127218.6 in Q1 2025, and up 19.67% on a QoQ basis from $84682.9 in Q4 2025.
Cardiol Therapeutics (CRDL) Non-Current Assets (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Non-Current Assets data on file, last reported at $101337.0 in Q1 2026.
- Quarterly Non-Current Assets fell 20.34% year-over-year to $101337.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406471.7 (down 46.3% YoY) and the FY2025 annual result came in at $84682.9, down 39.52% from the prior year.
- Non-Current Assets grew to $101337.0 in Q1 2026, from $84682.9 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $550723.8 in Q1 2022 to a low of $84682.9 in Q4 2025.
- A 5-year average of $302742.1 and a median of $363081.1 in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets fell 2.27% — and 2024, when it tumbled 65.18%.
- Tracing CRDL's Non-Current Assets over 5 years: stood at $435052.6 in 2022, then retreated by 7.58% to $402096.5 in 2023, then plunged by 65.18% to $140014.4 in 2024, then tumbled by 39.52% to $84682.9 in 2025, then grew by 19.67% to $101337.0 in 2026.
- The last three Non-Current Assets figures came in at $101337.0 (Q1 2026), $84682.9 (Q4 2025), and $102441.7 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 94,307.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101,336.99 |
| Dec 31, 2025 | 84,682.87 |
| Sep 30, 2025 | 102,441.73 |
| Jun 30, 2025 | 118,010.10 |
| Mar 31, 2025 | 127,218.62 |
| Dec 31, 2024 | 140,014.37 |
| Sep 30, 2024 | 174,412.47 |
| Jun 30, 2024 | 315,227.59 |
| Mar 31, 2024 | 363,081.11 |
| Dec 31, 2023 | 402,096.50 |
| Sep 30, 2023 | 450,147.41 |
| Jun 30, 2023 | 388,505.92 |
| Mar 31, 2023 | 426,414.98 |
| Dec 31, 2022 | 435,052.55 |
| Sep 30, 2022 | 460,618.21 |
| Jun 30, 2022 | 506,629.94 |
| Mar 31, 2022 | 550,723.83 |
| Dec 31, 2021 | 583,688.30 |
| Sep 30, 2021 | 628,639.12 |
| Jun 30, 2021 | 678,484.09 |